Novonix (ASX: NVX) shares tumbled 11% this week after Stellantis terminated a major supply agreement that was meant to anchor the company’s production ramp. The deal, signed in November 2024, covered up to 115,000 tonnes of synthetic graphite over six years. Losing this cornerstone customer raises questions about Novonix’s ability to meet automotive-grade specifications, yet the stock now trades more than 40% below recent highs despite intact partnerships with Panasonic and Volkswagen’s PowerCo. For risk-tolerant investors, this pullback could create a contrarian entry point.
What are the Best Graphite Stocks to invest in right now?
Why Novonix’s Technology Edge Still Matters
The Stellantis loss stings, but it doesn’t erase Novonix’s fundamental advantages in synthetic graphite production. The company’s proprietary induction furnace technology delivers lower energy consumption and significantly reduced emissions compared to conventional batch furnace systems used in China. This translates into a structural cost advantage at a time when Western automakers are desperate to reduce dependence on China, which controls over 95% of the global battery-grade graphite supply.
A life cycle assessment by sustainability firm Minviro found Novonix’s synthetic graphite has approximately 60% lower global warming potential compared to conventional Chinese production. With new US tariffs making Chinese imports more expensive, Novonix’s Tennessee-based production becomes increasingly attractive. The company’s Riverside facility is on track to become North America’s first large-scale synthetic graphite plant, with commercial production starting in 2025 for Panasonic.
What Wall Street Sees That ASX Investors Don’t
Here’s where the contrarian case gets interesting. Despite the Stellantis setback, Novonix has secured massive government backing that validates its strategic importance:
– US$100 million Department of Energy grant
– US$103 million investment tax credit
– US$754.8 million conditional DOE loan for the second facility
This level of government support doesn’t get awarded to companies with fundamentally flawed technology. The US government is betting heavily on Novonix because domestic graphite production is critical to energy security and reducing reliance on Chinese supply chains.
The company maintains binding agreements with Panasonic and PowerCo and continues supplying samples to 15 prospective customers across battery and industrial applications. Its planned second facility at Enterprise South would push total capacity beyond 50,000 tonnes annually, with strong customer interest already indicated for this additional volume.
The Buy Case: Risk Versus Reward at Current Levels
Trading around $0.50 per share, Novonix sits 50% below its 52-week high with a market cap under $500 million. This pricing appears to reflect maximum pessimism about execution risk while discounting the technology advantages, government support, and existing customer pipeline.
The Stellantis termination stemmed from disagreements over product specifications and production milestones and technical alignment issues rather than fundamental quality problems. For growth investors, this creates potential asymmetry: if Novonix successfully ramps production and secures additional offtake agreements over the next 12-18 months, today’s price could look attractive in hindsight.
The risks are real and significant. The company remains pre-revenue at commercial scale, continues burning cash, and faces the challenge of proving it can consistently meet automotive-grade specifications. Any further customer losses would be severely damaging, and production ramps in battery materials frequently encounter delays.
Our take: This is a high-risk, high-reward situation suitable only for investors who can stomach volatility and potential total loss. For those willing to accept the execution risk, Novonix at current levels offers leveraged exposure to the reshoring of Western battery supply chains, a multi-decade trend with strong government backing. Conservative investors should wait for proof of commercial production success before entering.
